N. Zamberlan

1.2k total citations
23 papers, 998 citations indexed

About

N. Zamberlan is a scholar working on Orthopedics and Sports Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, N. Zamberlan has authored 23 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Orthopedics and Sports Medicine, 10 papers in Oncology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in N. Zamberlan's work include Bone health and osteoporosis research (15 papers), Bone health and treatments (10 papers) and Bone and Joint Diseases (6 papers). N. Zamberlan is often cited by papers focused on Bone health and osteoporosis research (15 papers), Bone health and treatments (10 papers) and Bone and Joint Diseases (6 papers). N. Zamberlan collaborates with scholars based in Italy, United States and Belgium. N. Zamberlan's co-authors include Silvano Adami, Maurizio Rossini, Davide Gatti, S. Adámi, V. Braga, Francesco Bertoldo, Romolo M. Dorizzi, Vincenzo Lo Cascio, Roberto Castello and Flavia Tosi and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Mineral Research and Bone.

In The Last Decade

N. Zamberlan

23 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Zamberlan Italy 15 574 539 208 172 151 23 998
Larry M. Kohse United States 6 752 1.3× 586 1.1× 311 1.5× 82 0.5× 112 0.7× 7 980
Y. Boutsen Belgium 16 698 1.2× 485 0.9× 329 1.6× 96 0.6× 84 0.6× 40 1.2k
S. E. Papapoulos Netherlands 13 730 1.3× 453 0.8× 324 1.6× 113 0.7× 82 0.5× 36 1.1k
Silvano Adami Italy 13 926 1.6× 667 1.2× 319 1.5× 84 0.5× 111 0.7× 17 1.3k
Walter A. Merz Switzerland 5 433 0.8× 455 0.8× 257 1.2× 85 0.5× 97 0.6× 6 988
G. F. Mazzuoli Italy 15 586 1.0× 360 0.7× 311 1.5× 115 0.7× 90 0.6× 46 1.1k
M. Jesús Martínez de Osaba Spain 16 462 0.8× 374 0.7× 183 0.9× 135 0.8× 113 0.7× 23 882
D Kuntz France 18 469 0.8× 258 0.5× 357 1.7× 97 0.6× 67 0.4× 61 938
J. Dequeker Belgium 10 387 0.7× 136 0.3× 171 0.8× 85 0.5× 91 0.6× 11 663
Fergus E. McKiernan United States 15 465 0.8× 295 0.5× 164 0.8× 157 0.9× 153 1.0× 27 911

Countries citing papers authored by N. Zamberlan

Since Specialization
Citations

This map shows the geographic impact of N. Zamberlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Zamberlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Zamberlan more than expected).

Fields of papers citing papers by N. Zamberlan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Zamberlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Zamberlan. The network helps show where N. Zamberlan may publish in the future.

Co-authorship network of co-authors of N. Zamberlan

This figure shows the co-authorship network connecting the top 25 collaborators of N. Zamberlan. A scholar is included among the top collaborators of N. Zamberlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Zamberlan. N. Zamberlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moghetti, Paolo, Roberto Castello, N. Zamberlan, et al.. (1999). Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist1. The Journal of Clinical Endocrinology & Metabolism. 84(4). 1250–1254. 26 indexed citations
2.
Rossini, Maurizio, et al.. (1999). Intramuscular clodronate therapy in postmenopausal osteoporosis. Bone. 24(2). 125–129. 36 indexed citations
3.
Adami, S., N. Zamberlan, Roberto Castello, et al.. (1998). Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women. Clinical Endocrinology. 48(2). 169–173. 69 indexed citations
4.
Adámi, S., et al.. (1998). Bone Measurements in Asymptomatic Primary Hyperparathyroidism. Bone. 22(5). 565–570. 35 indexed citations
5.
Adami, S., N. Zamberlan, Roberto Castello, et al.. (1998). Effect of Hyperandrogenism and Menstrual Cycle Abnormalities on Bone Mass and Bone Turnover in Young Women. Obstetrical & Gynecological Survey. 53(8). 485–486. 4 indexed citations
6.
Zamberlan, N., Roberto Castello, Davide Gatti, et al.. (1997). Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist. Osteoporosis International. 7(2). 133–137. 8 indexed citations
7.
Adámi, S., N. Zamberlan, Davide Gatti, et al.. (1996). Computed radiographic absorptiometry and morphometry in the assessment of postmenopausal bone loss. Osteoporosis International. 6(1). 8–13. 46 indexed citations
8.
Gatti, Davide, Maurizio Rossini, N. Zamberlan, et al.. (1996). Effect of aging on trabecular and compact bone components of proximal and ultradistal radius. Osteoporosis International. 6(5). 355–360. 52 indexed citations
9.
Zamberlan, N., Giorgio Radetti, Davide Gatti, et al.. (1996). Evaluation of cortical thickness and bone density by roentgen microdensitometry in growing males and females. European Journal of Pediatrics. 155(5). 377–382. 47 indexed citations
10.
Adámi, S., Maurizio Rossini, Federico Schena, et al.. (1996). Exercise increases cortical/trabecular bone mass ratio. Osteoporosis International. 6(S1). 236–236. 1 indexed citations
11.
Adami, Silvano & N. Zamberlan. (1996). Adverse Effects of Bisphosphonates. Drug Safety. 14(3). 158–170. 306 indexed citations
12.
Zamberlan, N., Giorgio Radetti, Davide Gatti, et al.. (1996). Evaluation of cortical thickness and bone density by roentgen microdensitometry in growing males and females. European Journal of Pediatrics. 155(5). 377–382. 2 indexed citations
13.
Braga, V., Romolo M. Dorizzi, Giorgio Brocco, et al.. (1995). Clinical Utility of a Wheat-Germ Precipitation Assay for Determination of Bone Alkaline Phosphatase Concentrations in Patients with Different Metabolic Bone Diseases. Clinical Chemistry and Laboratory Medicine (CCLM). 33(7). 433–440. 8 indexed citations
14.
Adámi, S., N. Zamberlan, M. Mian, et al.. (1994). Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone. Bone and Mineral. 25(2). 75–82. 48 indexed citations
15.
Adámi, S., M. Mian, Pietro Gatti, et al.. (1994). Effects of two oral doses of alendronate in the treatment of Paget's disease of bone. Bone. 15(4). 415–417. 54 indexed citations
16.
Adami, S., V. Braga, N. Zamberlan, Davide Gatti, & Maurizio Rossini. (1993). Therapeutic strategies in osteoporosis : whom to treat and when treatment of postmenopausal bone loss : long-term strategies. Bone and Mineral. 22. 53–58. 1 indexed citations
17.
Adami, Silvano, Maurizio Rossini, N. Zamberlan, et al.. (1993). Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women. Maturitas. 17(3). 191–196. 48 indexed citations
18.
Adámi, S., Davide Gatti, Francesco Bertoldo, et al.. (1992). The effects of menopause and estrogen replacement therapy on the renal handling of calcium. Osteoporosis International. 2(4). 180–185. 48 indexed citations
19.
Adámi, S., V. Fossaluzza, M Rossini, et al.. (1992). 91288901 The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate. Maturitas. 14(3). 249–250. 6 indexed citations
20.
Adámi, S., V. Fossaluzza, Maurizio Rossini, et al.. (1991). The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate. Bone and Mineral. 15(1). 73–81. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Larry M. Kohse Breakdown of academic impact, for papers by Y. Boutsen Breakdown of academic impact, for papers by S. E. Papapoulos Breakdown of academic impact, for papers by Silvano Adami Breakdown of academic impact, for papers by Walter A. Merz Breakdown of academic impact, for papers by G. F. Mazzuoli Breakdown of academic impact, for papers by M. Jesús Martínez de Osaba Breakdown of academic impact, for papers by D Kuntz Breakdown of academic impact, for papers by J. Dequeker Breakdown of academic impact, for papers by Fergus E. McKiernan
Rankless by CCL
2026